NORRIS MEDICINES LTD.

Company Profile

NORRIS MEDICINES LTD. had its IPO on under the ticker symbol NORRIS.

The company operates in the Healthcare sector and Drug Manufacturers-Specialty & Generic industry. NORRIS MEDICINES LTD. has a staff strength of 58 employees.

Stock update

Shares of NORRIS MEDICINES LTD. opened at ₹11.4 at the start of the last trading session i.e. 2023-09-13.

The stocks traded within a range of ₹11.4 - ₹12, and closed at ₹11.5.

This is a +0.88% increase from the previous day's closing price.

A total volume of 1,907 shares were traded at the close of the day’s session.

In the last one week, shares of NORRIS MEDICINES LTD. have slipped by -4.09%.

NORRIS MEDICINES LTD.'s Key Ratios

NORRIS MEDICINES LTD. has a market cap of ₹349.52 million, indicating a price to book ratio of 0 and a price to sales ratio of 0.

In the last 12-months NORRIS MEDICINES LTD.’s revenue was ₹67.23 million with a gross profit of ₹30.75 million and an EBITDA of ₹-20049308. The EBITDA ratio measures NORRIS MEDICINES LTD.'s overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, NORRIS MEDICINES LTD.’s operating margin was -40.72% while its return on assets stood at -8.81% with a return of equity of 0%.

In Q2, NORRIS MEDICINES LTD.’s quarterly earnings growth was a positive 0% while revenue growth was a negative 37.8%.

NORRIS MEDICINES LTD.’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at ₹-2.606 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into NORRIS MEDICINES LTD.’s profitability.

NORRIS MEDICINES LTD. stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of 0. Its price to sales ratio in the trailing 12-months stood at 0.

NORRIS MEDICINES LTD. stock pays annual dividends of ₹ per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

₹0

Total Liabilities

₹0

Operating Cash Flow

₹0

Capital Expenditure

₹0

Dividend Payout Ratio

0%

NORRIS MEDICINES LTD. ended 2025 with ₹0 in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹0 while shareholder equity stood at ₹0.

NORRIS MEDICINES LTD. ended 2025 with ₹0 in deferred long-term liabilities, ₹0 in other current liabilities, in common stock, ₹0 in retained earnings and ₹0 in goodwill. Its cash balance stood at ₹0 and cash and short-term investments were ₹0. The company’s total short-term debt was ₹0 while long-term debt stood at ₹0.

NORRIS MEDICINES LTD.’s total current assets stands at ₹0 while long-term investments were ₹0 and short-term investments were ₹0. Its net receivables were ₹0 compared to accounts payable of ₹0 and inventory worth ₹0.

In 2025, NORRIS MEDICINES LTD.'s operating cash flow was ₹0 while its capital expenditure stood at ₹0.

Comparatively, NORRIS MEDICINES LTD. paid ₹0 in dividends in 2025.

Other key metrics

Current Trading Price

₹11.5

52-Week High

₹18

52-Week Low

₹8.85

Analyst Target Price

₹

NORRIS MEDICINES LTD. stock is currently trading at ₹11.5 per share. It touched a 52-week high of ₹18 and a 52-week low of ₹18. Analysts tracking the stock have a 12-month average target price of ₹.

Its 50-day moving average was ₹11.76 and 200-day moving average was ₹12.44 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.